Our analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.
John P. Caloyeras, MPhil
Advertisement
Articles by John P. Caloyeras, MPhil
Advertisement
Latest Updated Articles
- Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile Infection
Published: August 20th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
2
Therapeutic Cancer Vaccines: Are We There Yet?
3
Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings
4
FDA Approves Gazyva for Active Lupus Nephritis
5
